THE COST-EFFECTIVENESS OF TEMOZOLOMIDE IN THE ADJUVANT TREATMENT OF NEWLY DIAGNOSED GLIOBLASTOMA IN THE UNITED STATES

被引：0
|
作者：
Messali, A. [1 ]
Hay, J. [1 ]
Villacorta, R. [1 ]
机构：
[1] Univ So Calif, Los Angeles, CA USA
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 04期
关键词：
D O I：
10.1016/j.jval.2012.03.1195
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A221 / A222
页数：2
相关论文
共 50 条
  • [41] Cost-effectiveness of olaparib as a maintenance treatment for women with newly diagnosed advanced ovarian cancer and BRCA1/2 mutations in the United States
    Muston, Dominic
    Hettle, Robert
    Monberg, Matthew
    McLaurin, Kimmie K.
    Gao, Wei
    Swallow, Elyse
    Zhang, Su
    Kalemaj, Iden
    Signorovitch, James
    Moore, Kathleen
    GYNECOLOGIC ONCOLOGY, 2020, 159 (02) : 491 - 497
  • [42] Current survival statistics for patients with newly diagnosed glioblastoma treated with radiation and temozolomide on research studies in the United States
    Grossman, S. A.
    Ye, X.
    Piantadosi, S.
    Desideri, S.
    Nabors, L. B.
    Rosenfeld, M.
    Fisher, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [43] CHEMORADIOTHERAPY OF NEWLY DIAGNOSED GLIOBLASTOMA WITH INTENSIFIED TEMOZOLOMIDE
    Weiler, Markus
    Hartmann, Christian
    Wiewrodt, Dorothee
    Herrlinger, Ulrich
    Gorlia, Thierry
    Baehr, Oliver
    Meyermann, Richard
    Bamberg, Michael
    Tatagiba, Marcos
    von Deimling, Andreas
    Weller, Michael
    Wick, Wolfgang
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 77 (03): : 670 - 676
  • [44] ECONOMIC EVALUATION OF TEMOZOLOMIDE FOR THE TREATMENT OF NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME IN MEXICO
    Rely, K.
    Salinas, E. G.
    Pierre, K. A.
    VALUE IN HEALTH, 2009, 12 (03) : A42 - A42
  • [45] ECONOMIC EVALUATION OF TEMOZOLOMIDE FOR THE TREATMENT OF NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME IN MEXICO
    Rely, K.
    Salinas, E. G.
    Pierre, K. A.
    Dorantes, M. E. A.
    VALUE IN HEALTH, 2009, 12 (07) : A495 - A495
  • [46] Cost-effectiveness of vibegron for the treatment of overactive bladder in the United States
    Chen, Jing Voon
    Klein, Timothy M.
    Nesheim, Jeffrey
    Mudd, Paul N., Jr.
    JOURNAL OF MEDICAL ECONOMICS, 2022, 25 (01) : 1092 - 1100
  • [47] The Cost-effectiveness of Eltrombopag for the Treatment of Immune Thrombocytopenia in the United States
    Tremblay, Gabriel
    Dolph, Mike
    Roy, Anuja Nidumolu
    Said, Qayyim
    Forsythe, Anna
    CLINICAL THERAPEUTICS, 2020, 42 (05) : 860 - +
  • [48] A retrospective study of the safety of BCNU wafers with concurrent temozolomide and radiotherapy and adjuvant temozolomide for newly diagnosed glioblastoma patients
    Pan, Edward
    Mitchell, Susan B.
    Tsai, Jerry S.
    JOURNAL OF NEURO-ONCOLOGY, 2008, 88 (03) : 353 - 357
  • [49] A retrospective study of the safety of BCNU wafers with concurrent temozolomide and radiotherapy and adjuvant temozolomide for newly diagnosed glioblastoma patients
    Edward Pan
    Susan B. Mitchell
    Jerry S. Tsai
    Journal of Neuro-Oncology, 2008, 88 : 353 - 357
  • [50] Phase II trial of concurrent sunitinib, temozolomide, and radiotherapy with adjuvant temozolomide for newly diagnosed MGMT unmethylated glioblastoma
    Faye, Mame Daro
    Easaw, Jacob
    De Robles, Paula
    Agnihotram, Raman
    Torres-Vasquez, Alexander
    Lamonde, Frederic
    Petrecca, Kevin
    Owen, Scott
    Panet-Raymond, Valerie
    Shenouda, George
    Souhami, Luis
    Azam, Maryam
    Hossain, Bushra
    Alkass, Jad
    Sabri, Siham
    Abdulkarim, Bassam
    NEURO-ONCOLOGY ADVANCES, 2023, 5 (01)
12345